05.04.2024 • News

Brenntag Acquires Specialties Distributor in UK

German distribution giant Brenntag announced the acquisition of Lawrence Industries, an independent specialties distributor in the UK. The transaction, Brenntag said, further strengthens the company’s position within Material Science and across the coatings, adhesives, sealants and elastomers (CASE), construction, polymer and rubber industries. Financial details of the deal were not disclosed.

Lars Schneider, global president Brenntag Specialties Material Science, commented: “The acquisition of Lawrence Industries will further strengthen our specialty offering in the UK and Ireland and is perfectly in line with our strategy in Material Science. I look forward to further expanding our technical and value-added services to our top tier suppliers and valued customers with a particular focus on innovative and sustainable solutions, leveraging each other’s capabilities.”

Tamworth, Staffordshire-based Lawrence Industries supplies additives, minerals, and catalysts to a diverse range of markets across the UK and Ireland. The businesses generated sales of approximately £30 million in 2023.

“Gaining the international reach is an important next step for us as a leading distributor of specialty chemicals in the UK. Moreover, acquiring access to Brenntag’s extensive Innovation & Application Centre network enable our current and future customers to benefit from best-in-class value added services, said Charles Henn-Allen, managing director of Lawrence Industries.

© Brenntag
© Brenntag

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.